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Abstract Staphylococcus aureus, a major causative agent of human infection produces a large 1 
array of virulence factor including various toxins. Among them, the host RhoA GTPase ADP-2 
ribosylating EDIN toxins are considered as potential virulence factors. Using the polymerase 3 
chain reaction, we analyzed the virulence profile of 256 S. aureus isolates from various 4 
clinical sites of infections. We developed specific primers to detect the three isoforms of edin 5 
encoding genes. We found a prevalence of 14% (36 bacteria) of edin encoding genes among 6 
these clinical isolates. Strikingly, we found that 90% of all edin-bearing S. aureus isolates 7 
carried the type-C allele. Both the spa types and the profile of virulence factors of these edin-8 
positive isolates are highly variable. Notably, we show for the first time that edin-C positive 9 
isolates were more frequently recovered from deep-seated infections than other types of 10 
infections. Our present work thus strongly suggests that presence of edin-C is a risk factor of 11 
S. aureus dissemination in tissues and thus represents a predictive marker for a pejorative 12 
evolution of staphylococcal infections. 13 
 14 
 15 
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Introduction 1 
 2 
Staphylococcus aureus is a common bacterium, which is responsible for a unique variety of 3 
infections [1]. Development of pejorative forms of staphylococcal infections involves the 4 
combined action of numerous bacterial virulence factors, which corrupt host responses [2]. 5 
Bacterial virulence factors include specific adhesins, collectively referred as Microbial 6 
Surface Components Recognizing endothelial cell Adhesive Matrix Molecules 7 
(MSCRAMMs) and a large variety of toxins, such as the exfoliative toxins (ETs), hemolysin, 8 
leukocidin, enterotoxins and EDINs (epidermal cell differentiation inhibitors) [3-6]. 9 
EDINs belong to the family of Clostridium botulinum C3 exoenzyme [6, 7]. They are 10 
members of a group of major bacterial virulence factors targeting host Rho GTPases [4, 6-9]. 11 
Rho proteins control essential cellular processes such as cell polarity, movement and 12 
phagocytosis, as well as cohesion of intercellular junctions [6, 10, 11]. Recent findings 13 
suggest that EDINs might favor bacterial dissemination in tissues, by a haematogenous route, 14 
through induction of large transcellular tunnels in endothelial cells named macroapertures 15 
[12-14]. Indeed, recent data show that S. aureus EDIN toxin promotes formation of infection 16 
foci in a mouse model of bacteremia [15]. To date, three isoforms of EDIN have been 17 
characterized. These comprise the first discovered EDIN isoform (EDIN-A), isolated from the 18 
E-1 strain of S. aureus [16], as well as EDIN-B [6, 17] and EDIN-C [18]. The chromosomal 19 
gene encoding edin-B is located within a pathogenicity island frequently associated with the 20 
etD gene encoding the exfoliative toxin ET-D [17]. EDIN-C is encoded by the pETB plasmid, 21 
which also carries genes encoding ET-B and conferring cadmium resistance [18]. 22 
A first epidemiological survey, involving staphylococcal strains isolated from patients 23 
hospitalized for various infectious diseases demonstrated a higher prevalence of edin-24 
encoding genes in this group compared to nasal strains isolated from healthy students [19]. 25 
Another study shows that edin-B is present in 7% of bacteriemic S. aureus strains [17]. 26 
However, most other epidemiological data on edin are based on surveys focused on 27 
exfoliative toxins or PVL rather than EDIN toxin itself. For example, a genetic association 28 
between etD and edin-B was detected in the emerging ST80 clone Panton-Valentine 29 
Leukocidin (PVL)-positive and community-acquired (CA) methicillin-resistant S. aureus 30 
(MRSA) [20]. This clone is spreading throughout France and Tunisia and is most frequently 31 
associated with infections of the skin and soft tissues. Also, two-thirds of the strains 32 
belonging to the emerging ST123 epidemic European fusidic acid-resistant impetigo clone 33 
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(EEFIC) were positive for etB and sequence analysis of pETB2 (a close homolog of pETB) in 1 
one of these strains suggested that it also bears edin-C [21].  2 
In this study, we have developed a PCR-based method, to detect EDIN isoforms 3 
specifically. We demonstrate that 90% of all edin-bearing S. aureus isolates carry the type-C 4 
allele. We also show that these isolates are more significantly associated with deep-seated soft 5 
tissue infections than other types of infections (Fisher’s exact test, p=0.03).  6 
7 
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Materials and methods 1 
 2 
S. aureus isolates 3 
 4 
A total of 256 isolates of S. aureus belonging to the collection of the Bacteriology department 5 
of the Hospital University of Nice were analyzed. These isolates were recovered from 6 
randomly consecutive episodes of S. aureus infections in patients hospitalized during 2005. 7 
These isolates were obtained from various types of clinical samples, comprising blood 8 
cultures (28 bacteria); skin infections including chronic ulcers, burns or wounds (83 bacteria); 9 
urine samples (41 bacteria); sputum samples (69 bacteria); and various deep-seated soft tissue 10 
infections such as subcutaneous or visceral abscesses, spontaneously or post operative soft 11 
tissue infections (35 bacteria). For the last group, bacteria were isolated from specimens 12 
obtained by guidance radiography needle biopsy or during endoscopic and surgical 13 
procedures. All isolates were characterized using routine methods according to each 14 
manufacturer’s recommendations. All were positive for catalase, DNAse production and 15 
mannitol fermentation in Chapman medium, and confirmed to be S. aureus by specific 16 
32rapidStaph (BioMérieux, Marcy-l’Etoile, France). 17 
 18 
Antibiotic susceptibility determinations 19 
  20 
Antimicrobial susceptibility testing was performed on all isolates
 
obtained during the study 21 
using the disk diffusion method [22] on Mueller-Hinton medium (Difco Laboratories, Detroit, 22 
MI) according to the recommendations of the French Antibiogram Committee 23 
[http://www.sfm.asso.fr/nouv/general.php?pa=2]. Antibiotics tested were penicillin G, 24 
oxacillin, erythromycin, clindamycin and fusidic acid to focus on epidemiologic profiles. 25 
 26 
DNA isolation and PCR-based detection of genes 27 
 28 
For edin detection, total DNA was isolated from bacterial strains grown overnight at 37°C in 29 
BHI medium. Bacteria were lysed in 10 mM TrisHCl pH7.8, 100 mM NaCl, 1mM EDTA, 1% 30 
Triton X100. After incubation for 10 minutes at 100°C, DNA was collected and frozen. PCR 31 
amplification was used to detect the presence of edin-A, B and C using the primers described 32 
in Table 1. We have determined optimized thermal cycling conditions for edin-A (25 cycles of 33 
30s at 94°C, 45s annealing at 58°C and 1 min elongation at 72°C), edin-B (25 cycles of 30s at 34 
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95°C, 1 min annealing at 50°C and 1 min elongation at 72°C) and edin-C (30 cycles
 
of 30s at 1 
94°C, 45s annealing at 54°C and 1 min elongation at 72°C). For the detection of other 2 
virulence genes, total DNA was isolated from bacterial strains grown three hours at 37°C in 3 
BHI medium. DNA was subsequently
 
extracted with NucleoSpin Tissue (Macherey-Nagel 4 
GmbH, Düren, Germany) according to manufacturer’s recommendations. Briefly, bacteria 5 
were pelleted by centrifugation at 8,000
 
×g for 5 min, resuspended
 
in 180µl of lysis buffer
 
6 
with 33µl of proteinase K (20mg/ml) (Invitrogen Life Technologies, Carlsbad, CA) and 3µl of 7 
recombinant lysostaphin (3U/µl) (Sigma-Aldrich, St Louis, MI), and incubated for 60 min at 8 
37°C. DNA samples were eluted
 
with 100 µl alkaline elution buffer (BE buffer, NucleoSpin 9 
Tissue, Macherey-Nagel). The presence of 30 genes, among the most prevalent virulence-10 
associated genes, was evaluated by PCR as described previously: staphylococcal enterotoxins 11 
(se) A, B, C, D, E, G, H, I, J, K, and Q, toxic shock syndrome toxin 1 (tst-1), exfoliative 12 
toxins A, B and D (etA, etB, etD), PVL (lukS-PV
_
lukF-PV), LukDE leukocidin (lukE), nine 13 
MSCRAMM (bbp, cna, ebpS, clfA, clfB, fib, fnbA, fnbB, eno). The accessory gene regulator 14 
(agr) allele group was determined by multiplex PCR.  15 
 16 
spa sequencing 17 
 18 
spa typing was performed as described previously [23], using the spa typing website 19 
(http://www.spaserver.ridom.de/) that is developed by Ridom GmbH and curated by 20 
SeqNet.org (http://www.SeqNet.org/). Primers are indicated in Table 1. 21 
 22 
Statistical analysis  23 
 24 
The chi-square or Fisher’s exact test for categorical variables was used to compare data as 25 
appropriate. A P value of less than 0.05 was considered significant. 26 
27 
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Results 1 
 2 
Detection of edin isoforms 3 
 4 
 S. aureus isolates analyzed in this study were collected at the university hospital of Nice from 5 
various infected patients.   We designed primers with high sensitivity and specificity in order 6 
to detect, by PCR, edin-A, B and C alleles in these isolates. This was especially challenging 7 
for edin-C, which was poorly detected using a previously described pair of primers designed 8 
to amplify all edin isoforms. This is consistent with the fact that the sequence of edin-C has 9 
the most substantial sequence variations in regions recognized by these primer sequences 10 
(17% and 32% homology with the forward and reverse primers, respectively) (Fig. 1) [19]. As 11 
shown in figure 1, the three pairs of primers designed allowed us to amplify specifically a 455 12 
bp DNA fragment for edin-A and B, and a 320 bp DNA fragment for edin-C.  13 
We next analyze the 256 clinical isolates of S. aureus. We found that 14 % (36) of these 14 
isolates were positive for one of the edin alleles. Among these 36 isolates, 90% were positive 15 
for edin-C and 5% were positive for either edin-A or B. To confirm the nature of the edin 16 
isoforms, we performed complete sequence analysis of five edin-C encoding genes from 17 
randomly selected isolates. We also sequenced edin-A and edin-B encoding genes. These 18 
results confirm the specificity of the new primers used and demonstrate that edin-C was more 19 
prevalent than other alleles of edin.  20 
 21 
Detection of genes encoding virulence factors 22 
 23 
The 36 isolates positive for edin genes were next analyzed for the distribution of major 24 
MSCRAMMs, various staphylococcal enterotoxins, exfoliative toxins, the toxic shock 25 
syndrome toxin 1 gene tst-1, as well as leucotoxin family encoding genes. Among the 26 
staphylococcal MSCRAMM genes, eno, clfA and clfB were detected in all edin-positive 27 
isolates (Table 2). bbp, fnbA and ebpS were the less frequently encountered MSCRAMMs 28 
among these isolates. However these adhesion factors had no preferential distribution among 29 
S. aureus isolated from various types of infections. Among the staphylococcal enterotoxins 30 
genes the most frequently encountered were seg, sei and sea (Table 2). In addition, 72% of 31 
edin-positive isolates (26 bacteria) contained a combination of these three genes. One edin-C 32 
bearing isolate, isolated from a urine sample, had only the sea enterotoxin gene. We detected 33 
the exfoliative toxin gene etD exclusively among the edin-B positive isolates. Two edin-A 34 
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positive isolates carried the staphylococcal exfoliative gene etB. We found that 25 edin-C 1 
positive S. aureus (78%) were negative for etA, etB and etD exfoliative toxin encoding genes. 2 
We observed that only 22% of the edin-C positive S. aureus (7 out of 32) had at least one of 3 
the two isoforms (etA or etB) of the exfoliative toxin gene. Five of these seven isolates carried 4 
both the etA and etB genes. No significant association was found between the presence of tst-5 
1, exfoliative toxins or leucotoxin family encoded genes and the types of infection. Finally, a 6 
large number of edin-positive S. aureus belonged to the agr group 1 (50%, 18 bacteria), and 7 
to a lesser extent, to agr groups 2, 3 and 4 (17%, 6 bacteria each) (Table 2).  8 
 9 
spa-typing 10 
 11 
Determination of the spa type of 26 edin-positive isolates [23] allowed us to exclude the 12 
clonal origin of all edin-C positive S. aureus in our survey. Among them, only six isolates 13 
could be classified as ST45 (two isolates), ST30 (two isolates), ST59 or ST26. The other 20 14 
isolates showed a high variability of their spa type (Table 3). For 14 isolates, we determined 15 
new repeat sequences including unidentified 24-bp repeats thus defining new spa types. 16 
Among them, bacteria S7926 and S7262, isolated respectively in deep seated soft tissue and 17 
sputum sample from unrelated infected patients, presented the same spa type t6956 (Table 3). 18 
Together these data excluded the clonal origin of all edin-C positive S. aureus in our survey.   19 
 20 
Antibiotic susceptibility profiles 21 
 22 
We next investigated whether edin-positive isolates were associated with specific antibiotic 23 
resistance profiles, such as community-acquired methicillin resistant S. aureus ST80 and 24 
fusidic acid-resistant impetigo clones [20, 21]. In relation with these studies, we determined 25 
the minimum inhibitory concentrations (MICs) of edin-positive isolates for the following 26 
antibiotics: penicillin G, methicillin, erythromycin, clindamycin and fusidic acid. Results 27 
were presented in Table 2.  Only one isolate, positive for edin-C, showed a methicillin-28 
resistance. Finally, edin-positive isolates did not show any specific resistance profile to 29 
classical antibiotics used to cure infections by S. aureus (Table 2). 30 
 31 
Clinical origin of edin-positive S. aureus 32 
 33 
  9 
Having shown no link between a high prevalence of edin-C within our S. aureus isolates and 1 
any phenotypic profile or clonal origin, we further analyzed the distribution of edin-positive 2 
isolates with regard to the infectious sites. We noticed that isolates positive for edin-C were 3 
recovered at all sites of infection (Table 4). Strikingly, edin-positive S. aureus were more 4 
significantly associated with deep-seated infections of soft tissues than other types of 5 
infections (25.7%, Fischer exact test, p=0.03). No significant association was detected 6 
between edin-positive or edin-negative isolates and other types of infections (blood, urine, 7 
superficial soft tissue and sputum culture). 8 
 9 
10 
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Discussion 1 
 2 
Our study shows that edin-positive S. aureus isolates are found in all types of clinical 3 
infections included in this study, with a global prevalence of 14%. Moreover, we show that 4 
90% of edin-positive isolates are positive for edin-C. This is consistent with a previous study 5 
performed with specific primers, which also reported a higher prevalence of edin-C in clinical 6 
isolates of S. aureus in Japan [24]. This points for the need of using specific primers to detect 7 
each edin isoform, especially edin-C, given its high prevalence. On the contrary, both studies 8 
point for a possible underestimation of the prevalence of edin-C in pathogenic S. aureus when 9 
consensus primers were used. Both the analysis of spa type and the distribution of various 10 
virulence factors among edin-positive S. aureus show their high genetic variability. Our 11 
results on the distribution of MSCRAMMs are consistent with previous findings [25]. 12 
Classically, edin and exfoliative toxin encoding genes are associated in specific lineages 13 
responsible for skin infections [17, 21, 24]. Interestingly, here we show that edin-C is not 14 
strictly associated with genes encoding exfoliative toxin of serotypes A/B/D (7 bacteria edin-15 
C-positive and et-positive, versus 25 bacteria edin-C-positive and et-negative). The high 16 
prevalence of edin-C-positive and et-negative isolates observed in our study might be 17 
explained by the plasticity of the pETB plasmid, which has been previously reported in two 18 
different variants [18, 21]. Also, a recent study shows genetic variations in pathogenicity 19 
islands encoding EDIN-B [17]. 20 
Given that spa analysis constitutes a good tool for epidemiological typing of S. aureus 21 
[26], the use of this method allowed us to exclude the clonal origin of edin-C positive isolates.  22 
The fact that edin-C is plasmid born might explain its presence in isolates of various genetic 23 
backgrounds. 24 
S. aureus positive for edin are more frequently associated with deep-seated infections of 25 
soft tissues. We have previously established that infection of endothelial cells, and other cell 26 
types, by EDIN-producing S. aureus triggers the formation of transcellular tunnels named 27 
macroapertures [12, 13]. Opening of transcellular tunnels in the endothelium suggested that 28 
EDIN might favour bacterial extravasation in tissues during bacteremia. In a mouse model of 29 
intravascular injection of S. aureus, we have observed that EDIN plays no detectable role in 30 
the persistence of bacteria in the blood stream [15]. This data is consistent with the absence of 31 
a higher prevalence of edin positive S. aureus recovered from patients associated bacteriemia 32 
in this study. In contrast, in this model of mouse infection EDIN toxin promotes formation of 33 
infection foci [15]. This suggested that EDIN might enhance the invasive capacity of S. 34 
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aureus. The hypothesis of a role of EDIN in S. aureus infection is also supported by our 1 
present findings showing that S. aureus associated with deep-seated infections of soft tissues 2 
have a higher prevalence of edin. However, whether or not edin-positive S. aureus is 3 
preferentially associated with a specific type of deep seated infection remains to be further 4 
determined”.  5 
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Figure legend 1 
 2 
Fig. 1 Characterization of the three edin alleles. A) PCR amplification of edin-A, edin-B and 3 
edin-C from S. aureus strains S25edin-A(+)[15], S7256edin-B(+) and S7475edin-C(+) (this 4 
study), respectively, using specific oligonucleotides edinA, edinB, edinC (Table 1) and the 5 
previously described edin oligonucleotides referred as edinX  [19]. B) Sequence alignments of 6 
edin-A, edin-B and edin-C showing sequence homologies and localization of each 7 
oligonucleotide (underlined: edinX; highlighted: edinA, edinB and edinC). 8 
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 14 
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Table 1: Oligonucleotides primers used in this study 1 
 2 
Gene  Primer sequences Size 
(kb) 
References 
edinA Sense 5’-GGAGATATTAATAAGCTAGATTC-3’ 
Antisense 5’-ATTTTCTTTTTATCATTTGACAATTCT-3’ 
455 This study 
edinB Sense 5’-GGTGACGTGAACAAATTATCCGA-3’ 
Antisense 5’-ATCTTTCTTTTGTTATCAGAAAGTTTA-3’ 
455 This study 
edinC Sense 5’-CGCCATTAAGGTCTAGTCAAGG-3’ 
Antisense 5’-TAGGTCTTCCAGCTAATGCAGC-3’ 
320 This study 
bbp Sense 5’-AACTACATCTAGTACTCAACAACAG-3’ 
Antisense 5’-ATGTGCTTGAATAACACCATCATCT-3’ 
575 [25] 
cna Sense 5’-GTCAAGCAGTTATTAACACCAGAC-3’ 
Antisense 5’-AATCAGTAATTGCACTTTGTCCACTG-3’ 
423 [25] 
ebpS Sense 5’-CATCCAGAACCAATCGAAGAC-3’ 
Antisense 5’-CTTAACAGTTACATCATCATGTTTATCTTTG-3’ 
186 [25] 
fnbA Sense 5’-GTGAAGTTTTAGAAGGTGGAAAGATTAG -3’ 
Antisense 5’-GCTCTTGTAAGACCATTTTTCTTCAC-3’ 
643 [25] 
fnbB Sense 5’-GTAACAGCTAATGGTCGAATTGATACT-3’ 
Antisense 5’-CAAGTTCGATAGGAGTACTATGTTC-3’ 
524 [25] 
fib Sense 5’-CTACAACTACAATTGCCGTCAACAG-3’ 
Antisense 5’-GCTCTTGTAAGACCATTTTCTTCAC-3’ 
404 [25] 
clfA Sense 5’-ATTGGCGTGGCTTCAGTGCT-3’ 
Antisense 5’-CGTTTCTTCCGTAGTTGCATTTG-3’ 
292 [25] 
clfB Sense 5’-ACATCAGTAATAGTAGGGGGCAAC-3’ 
Antisense 5’-TTCGCACTGTTTGTGTTTGCAC-3’ 
205 [25] 
eno Sense 5’- ACGTGCAGCAGCTGACT-3’ 
Antisense 5’- CAACAGCATYCTTCAGTACCTTC-3’ 
302 [25] 
sea  Sense 5’-GCAGGGAACAGCTTTAGGC-3’ 
Antisense 5’-GTTCTGTAGAAGTATGAAACACG-3’ 
520 [27] 
seb Sense 5’-ATGTAATTTTGATATTCGCAGTG-3’ 
Antisense 5’-TGCAGGCATCATATCATACCA-3’ 
683 [27] 
sec Sense 5’-CTTGTATGTATGGAGGAATAACAA-3’ 283 [27] 
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Antisense 5’-TGCAGGCATCATATCATACCA-3’ 
sed Sense 5’-GTGGTGAAATAGATAGGACTGC-3’ 
Antisense 5’-ATATGAAGGTGCTCTGTGG-3’ 
384 [27] 
see Sense 5’-TACCAATTAACTTGTGGATAGAC-3’ 
Antisense 5’-CTCTTTGCACCTTACCGC-3’ 
170 [27] 
seg Sense 5’-CGTCTCCACCTGTTGAAGG-3’ 
Antisense 5’-CCAAGTGATTGTCTATTGTCG-3’ 
327 [27] 
seh Sense 5’-CAACTGCTGATTTAGCTCAG-3’ 
Antisense 5’-GTCGAATGAGTAATCTCTAGG-3’ 
360 [27] 
sei Sense 5’-CAACTCGAATTTTCAACAGGTAC-3’ 
Antisense 5’- CAGGCAGTCCATCTCCTG-3’ 
465 [27] 
sej Sense 5’- CATCAGAACTGTTGTTCCGCTAG-3’ 
Antisense 5’- CTGAATTTTACCATCAAAGGTAC-3’ 
142 [27] 
sek Sense 5’- ATGGCGGAGTCACAGCTACT-3’ 
Antisense 5’-TGCCGTTATGTCCATAAATGTT-3’ 
197 [27] 
seq Sense 5’-GAACCTGAAAAGCTTCAAGGA-3’ 
Antisense 5’-ATTCGCCAACGTAATTCCAC-3’ 
209 [27] 
eta  Sense 5’-CTAGTGCATTTGTTATTCAA-3’ 
Antisense 5’-TGCATTGACACCATAGTACT-3’ 
119 [28] 
etb Sense 5’-ACGGCTATATACATTCAATT-3’  
Antisense 5’-TCCATCGATAATATACCTAA-3’ 
200 [28] 
etd Sense 5'-ATGACTAAAAATATATTAAAAAGTT-3’ 
Antisense 5‘-CTAATGAGACTGTAATTCAGC-3’ 
846 This study 
lukPV Sense 5’-ATCATTAGGTAAAATGTCTGGACATGATCCA-3’ 
Antisense 5’-GCATCAASTGTATTGGATAGCAAAAGC-3’ 
433 [29] 
lukE Sense 5’-TGAAAAAGGTTCAAAGTTGATACGAG-3’ 
Antisense 5’-TGTATTCGATAGCAAAAGCAGTGCA-3’  
269 [29] 
tst-1 Sense 5’-GCTTGCGACAACTGCTACAG-3’ 
Antisense 5’-TGGATCCGTCATTCATTGTTAA-3’ 
559 [27] 
agr1 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-GTCACAAGTACTATAAGCTGCGAT-3’ 
439 [30] 
agr2 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-TATTACTAATTGAAAAGTGC CATAGC-3’ 
572 [30] 
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agr3 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-GTAATGTAATAGCTTGTATAATAATACCCAG-3’ 
321 [30] 
agr4 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-CGATAATGCCGTAATACCCG-3’ 
657 [30] 
spa Sense5’-TGTAAAACGACGGCCAGTTAAAGACGATCCTTCGGTGAGC-3’ 
Antisense5’-CAGGAAACAGCTATGACCCAGCAGTAGTGCCGTTTGCTT-3’ 
 [23] 
 1 
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Table 2: Virulence profile and antibiotic susceptibility of clinical edin-positive S. aureus isolates. 
n % n % n % n % n % n %
Virulence profile
MSCRAMMs
bbp 0 0 3 27 3 75 3 30 6 67 15 42
cna 1 50 9 82 4 100 10 100 8 89 32 89
ebpS 0 0 5 45 1 25 6 60 6 67 18 50
fnbA 1 50 7 64 1 25 5 50 5 56 19 53
fnbB 1 50 11 100 4 100 7 70 8 89 31 86
fib 2 100 10 91 4 100 7 70 9 100 32 89
clfA 2 100 11 100 4 100 10 100 9 100 36 100
clfB 2 100 11 100 4 100 10 100 9 100 36 100
eno 2 100 11 100 4 100 10 100 9 100 36 100
SEs
sea 1 50 10 91 3 75 9 90 9 100 32 89
seb 1 50 7 64 2 50 8 80 6 67 24 67
sec 1 50 7 64 2 50 10 100 6 67 26 72
sed 0 0 8 73 3 75 6 60 6 67 23 64
see 0 0 0 0 0 0 0 0 0 0 0 0
sek 1 50 5 45 1 25 7 70 2 22 16 44
seq 1 50 3 27 1 25 5 50 5 56 15 42
seg 2 100 10 91 2 50 10 100 9 100 33 92
seh 0 0 0 0 0 0 0 0 1 11 1 3
sei 2 100 11 100 2 50 9 90 8 89 32 89
sej 0 0 1 9 0 0 2 20 1 11 4 11
tst-1 2 100 6 55 1 25 7 70 5 56 21 58
etA 0 0 2 18 0 0 2 20 2 22 6 17
etB 1
&
50 4
$
36 0 0 2 20 1 11 8 22
etD 0 0 0 0 1* 25 1* 10 0 0 2 6
lukPV 0 0 1 9 1 25 0 0 3 33 5 14
lukE 2 100 8 73 3 75 5 50 4 44 24 67
agr group
agr1 1 50 3 27 3 75 6 60 5 56 18 50
agr2 1 50 3 27 1 25 1 10 0 0 6 17
agr3 0 0 3 27 0 0 0 0 3 33 6 17
agr4 0 0 2 18 0 0 3 30 1 11 6 17
antibiotic resistance profile
penicillin G 1 50 5 45 2 50 8 80 6 67 22 61
Methicillin 0 0 0 0 0 0 0 0 1 11 1 3
Erythromycin 0 0 1 9 0 0 1 10 1 11 3 8
Clindamycin 0 0 0 0 0 0 0 0 1 11 1 3
Fusidic acid 0 0 0 0 1¤ 25 0 0 1¤ 11 2 6
* Edin B positive strains
$
 Edin A  positive for one strain
& 
EdinA positive strain
¤ Increase in fusidic acid MIC, classified as intermediary sensibility
blood (n=2)
superficial soft tissue 
(n=11)
urine sample (n=4) sputum sample (n=10)
deep-seated soft tissue 
(n=9)
total (n=36)
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Table  3 : spa-type of 36 edin-positive Staphylococcus aureus isolates. 
 
Strains EDIN type Spa-type or repeat sequences MLST 
Blood 
S25 A t6403 - 
S7232 C NT
$
 - 
Deep-seated soft tissue  
S7272 C t6953 - 
S7404 C t6649 - 
S7408 C t6484 - 
S7466 C t012 ST-30 
S7595 C NT - 
S7600 C t6677 - 
S7926 C t6956 - 
S8028* C NT - 
S8087 C t6481 - 
Sputum sample 
S7225 C t2726 - 
S7259 C t2088 - 
S7262 C t6956 - 
S7413 C t6483 - 
S7535 C t2647 - 
S7634 C t6954 - 
S7649 B NT - 
S7920 C NT - 
S7965 C NT - 
S8100 C t015 ST-45 
Superficial soft tissue 
S7181 C t6650 - 
S7183 C NT - 
S7436 C t6957 - 
S7475 C t6480 - 
S7526 C t137 - 
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S7539 C NT - 
S7569 A t031 ST-45 
S7599 C t6482 - 
S7932 C NT - 
S7938 C t620 - 
S7977 C NT - 
Urine sample 
S7256 B t078 ST-26 
S7322 C t012 ST-30 
S7906 C t645 - 
S7946 C t216 ST-59 
* MRSA bacteria 
$
 Not typable 
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Table 4: Presence of edin genes in 256 Staphylococcus aureus isolates associated with various 
clinical syndromes. 
Source of isolates (N) 
Number of edin 
isolates       (%) 
edin-isoforms 
edinA edinB edinC 
Blood (28) 2 (7.1) 1 0 1 
Urine (41) 4 (9.8) 0 1 3 
Superficial soft tissue (83) 11 (13.3) 1 0 10 
Deep-seated soft tissue (35) 9 (25.7)* 0 0 9 
Sputum (69) 10 (14.5) 0 1 9 
Total (256) 36 (14) 2 (5) 2 (5) 32 (90) 
* p<0,05 (Fisher’s exact test) 
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Abstract Staphylococcus aureus, a major causative agent of human infection produces a large 
array of virulence factor including various toxins. Among them, the host RhoA GTPase 
targeting EDIN toxins are considered as potential virulence factors. Using the polymerase 
chain reaction, we analyzed the virulence profile of 256 S. aureus strains isolated from 
various clinical sites of infections. We developed specific primers to detect the three isoforms 
of edin encoding genes. We found a prevalence of 14% (36 strains) of edin encoding genes 
among these clinical strains. Strikingly, we found that 90% of all edin-bearing S. aureus 
strains carried the type-C allele. Both the spa types and the profile of virulence factors of 
these edin-positive strains are highly variable. Notably, we show for the first time that edin-C 
positive strains were more frequently recovered from deep-seated infections than other types 
of infections. Our present work thus strongly suggests that presence of edin-C is a risk factor 
of S. aureus dissemination in tissues and thus represents a predictive marker for a pejorative 
evolution of staphylococcal infections. 
 
 
 
Keywords 
Staphylococcus aureus, EDIN, toxin, ADP-ribosyltransferase, virulence factors, Rho 
GTPases. 
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Introduction 
 
Staphylococcus aureus is a common bacterium, which is responsible for a unique variety of 
infections [1]. Development of pejorative forms of staphylococcal infections involves the 
combined action of numerous bacterial virulence factors, which corrupt host responses [2]. 
Bacterial virulence factors include specific adhesins, collectively referred as Microbial 
Surface Components Recognizing endothelial cell Adhesive Matrix Molecules 
(MSCRAMMs) and a large variety of toxins, such as the exfoliative toxins (ETs), hemolysin, 
leukocidin, enterotoxins and EDINs (epidermal cell differentiation inhibitors) [3-6]. 
EDINs belong to the family of Clostridium botulinum C3 exoenzyme [6, 7]. They are 
members of a group of major bacterial virulence factors targeting host Rho GTPases [4, 6-9]. 
Rho proteins control essential cellular processes such as cell polarity, movement and 
phagocytosis, as well as cohesion of intercellular junctions [6, 10, 11]. Recent findings 
suggest that EDINs might favor bacterial dissemination in tissues, by a haematogenous route, 
through induction of large transcellular tunnels in endothelial cells named macroapertures 
[12-14]. Indeed, recent data show that S. aureus EDIN toxin promotes formation of infection 
foci in a mouse model of bacteremia [15]. To date, three isoforms of EDIN have been 
characterized. These comprise the first discovered EDIN isoform (EDIN-A), isolated from the 
E-1 strain of S. aureus [16], as well as EDIN-B [6, 17] and EDIN-C [18]. The chromosomal 
gene encoding edin-B is located within a pathogenicity island frequently associated with the 
etD gene encoding the exfoliative toxin ET-D [17]. EDIN-C is encoded by the pETB plasmid, 
which also carries genes encoding ET-B and conferring cadmium resistance [18]. 
A first epidemiological survey, involving staphylococcal strains isolated from patients 
hospitalized for various infectious diseases demonstrated a higher prevalence of edin-
encoding genes in this group compared to nasal strains isolated from healthy students [19]. 
Another study shows that edin-B is present in 7% of bacteriemic S. aureus strains [17]. 
However, most other epidemiological data on edin are based on surveys focused on 
exfoliative toxins or PVL rather than EDIN toxin itself. For example, a genetic association 
between etD and edin-B was detected in the emerging ST80 clone Panton-Valentine 
Leukocidin (PVL)-positive and community-acquired (CA) methicillin-resistant S. aureus 
(MRSA) [20]. This clone is spreading throughout France and Tunisia and is most frequently 
associated with infections of the skin and soft tissues. Also, two-thirds of the strains 
belonging to the emerging ST123 epidemic European fusidic acid-resistant impetigo clone 
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(EEFIC) were positive for etB and sequence analysis of pETB2 (a close homolog of pETB) in 
one of these strains suggested that it also bears edin-C [21].  
In this study, we have developed a PCR-based method, to detect EDIN isoforms 
specifically. We demonstrate that 90% of all edin-bearing S. aureus strains carry the type-C 
allele. We also show that these strains are more significantly associated with deep-seated soft 
tissue infections than other types of infections (Fisher’s exact test, p=0.03).  
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Materials and methods 
 
S. aureus isolates 
 
A total of 256 strains of S. aureus were retrospectively collected from patients hospitalized at 
the university hospital of Nice during 2005. These strains were obtained from various types of 
clinical samples, comprising blood cultures (28 strains); skin infections including chronic 
ulcers, burns or wounds (83 strains); urine samples (41 strains); sputum samples (69 strains); 
and various deep-seated soft tissue infections such as subcutaneous or visceral abscesses, 
spontaneously or post operative soft tissue infections (35 strains). All isolates were 
characterized using routine methods according to each manufacturer’s recommendations. All 
were positive for catalase, DNAse production and mannitol fermentation in Chapman 
medium, and confirmed to be S. aureus by specific 32rapidStaph (BioMérieux, Marcy-
l’Etoile, France). 
 
Antibiotic susceptibility determinations 
  
Antimicrobial susceptibility testing was performed on all isolates
 
obtained during the study 
using the disk diffusion method [22] on Mueller-Hinton medium (Difco Laboratories, Detroit, 
MI) according to the recommendations of the French Antibiogram Committee 
[http://www.sfm.asso.fr/nouv/general.php?pa=2]. Antibiotics tested were penicillin G, 
oxacillin, erythromycin, clindamycin and fusidic acid to focus on epidemiologic profiles. 
 
DNA isolation and PCR-based detection of genes 
 
For edin detection, total DNA was isolated from bacterial strains grown overnight at 37°C in 
BHI medium. Bacteria were lysed in 10 mM TrisHCl pH7.8, 100 mM NaCl, 1mM EDTA, 1% 
Triton X100. After incubation for 10 minutes at 100°C, DNA was collected and frozen. PCR 
amplification was used to detect the presence of edin-A, B and C using the primers described 
in Table 1. We have determined optimized thermal cycling conditions for edin-A (25 cycles of 
30s at 94°C, 45s annealing at 58°C and 1 min elongation at 72°C), edin-B (25 cycles of 30s at 
95°C, 1 min annealing at 50°C and 1 min elongation at 72°C) and edin-C (30 cycles
 
of 30s at 
94°C, 45s annealing at 54°C and 1 min elongation at 72°C). For the detection of other 
virulence genes, total DNA was isolated from bacterial strains grown three hours at 37°C in 
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BHI medium. DNA was subsequently
 
extracted with NucleoSpin Tissue (Macherey-Nagel 
GmbH, Düren, Germany) according to manufacturer’s recommendations. Briefly, bacteria 
were pelleted by centrifugation at 8,000
 
×g for 5 min, resuspended
 
in 180µl of lysis buffer
 
with 33µl of proteinase K (20mg/ml) (Invitrogen Life Technologies, Carlsbad, CA) and 3µl of 
recombinant lysostaphin (3U/µl) (Sigma-Aldrich, St Louis, MI), and incubated for 60 min at 
37°C. DNA samples were eluted
 
with 100 µl alkaline elution buffer (BE buffer, NucleoSpin 
Tissue, Macherey-Nagel). The presence of 30 genes, among the most prevalent virulence-
associated genes, was evaluated by PCR as described previously: staphylococcal enterotoxins 
(se) A, B, C, D, E, G, H, I, J, K, and Q, toxic shock syndrome toxin 1 (tst-1), exfoliative 
toxins A, B and D (etA, etB, etD), PVL (lukS-PV
_
lukF-PV), LukDE leukocidin (lukE), nine 
MSCRAMM (bbp, cna, ebpS, clfA, clfB, fib, fnbA, fnbB, eno). The accessory gene regulator 
(agr) allele group was determined by multiplex PCR.  
 
spa sequencing 
 
spa typing was performed as described previously [23], using the spa typing website 
(http://www.spaserver.ridom.de/) that is developed by Ridom GmbH and curated by 
SeqNet.org (http://www.SeqNet.org/). Primers are indicated in Table 1. 
 
Statistical analysis  
 
The chi-square or Fisher’s exact test for categorical variables was used to compare data as 
appropriate. A P value of less than 0.05 was considered significant. 
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Results 
 
Detection of edin isoforms 
 
 S. aureus isolates analyzed in this study were collected at the university hospital of Nice from 
various infected patients.   We designed primers with high sensitivity and specificity in order 
to detect, by PCR, edin-A, B and C alleles in these strains. This was especially challenging for 
edin-C, which was poorly detected using a previously described pair of primers designed to 
amplify all edin isoforms. This is consistent with the fact that the sequence of edin-C has the 
most substantial sequence variations in regions recognized by these primer sequences (17% 
and 32% homology with the forward and reverse primers, respectively) (Fig. 1) [19]. As 
shown in figure 1, the three pairs of primers designed allowed us to amplify specifically a 455 
bp DNA fragment for edin-A and B, and a 320 bp DNA fragment for edin-C.  
We next analyze the 256 clinical strains of S. aureus. We found that 14 % (36) of these 
strains were positive for one of the edin alleles. Among these 36 strains, 90% were positive 
for edin-C and 5% were positive for either edin-A or B. To confirm the nature of the edin 
isoforms, we performed complete sequence analysis of five edin-C encoding genes from 
randomly selected strains. We also sequenced edin-A and edin-B encoding genes. These 
results confirm the specificity of the new primers used and unravel that edin-C was more 
prevalent than other alleles of edin.  
 
Detection of genes encoding virulence factors 
 
The 36 strains positive for edin genes were next analyzed for the distribution of major 
MSCRAMMs, various staphylococcal enterotoxins, exfoliative toxins, the toxic shock 
syndrome toxin 1 gene tst-1, as well as leucotoxin family encoding genes. Among the 
staphylococcal MSCRAMM genes, eno, clfA and clfB were detected in all edin-positive 
strains (Table 2). bbp, fnbA and ebpS were the less frequently encountered MSCRAMMs 
among these strains. However these adhesion factors had no preferential distribution among 
S. aureus isolated from various types of infections. Among the staphylococcal enterotoxins 
genes the most frequently encountered were seg, sei and sea (Table 2). In addition, 72% of 
edin-positive strains (26 strains) presented a combination of these three genes. One edin-C 
bearing strain, isolated from a urine sample, had only the sea enterotoxin gene. We detected 
the exfoliative toxin gene etD exclusively among the edin-B positive strains. Two edin-A 
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positive strains carried the staphylococcal exfoliative gene etB. We found that 25 edin-C 
positive S. aureus (78%) were negative for etA, etB and etD exfoliative toxin encoding genes. 
We observed that only 22% of the edin-C positive S. aureus (7 out of 32) had at least one of 
the two isoforms (etA or etB) of the exfoliative toxin gene. Five of these seven strains carried 
both the etA and etB genes. Finally, a large number of edin-positive S. aureus belonged to the 
agr group 1 (50%, 18 strains), and to a lesser extent, to agr groups 2, 3 and 4 (17%, 6 strains 
each) (Table 2).  
 
spa-typing 
 
Determination of the spa type of 26 edin-positive strains [23] allowed us to exclude the clonal 
origin of all edin-C positive S. aureus in our survey. Among them, only six strains could be 
classified as ST45 (two isolates), ST30 (two isolates), ST59 or ST26. The other 20 strains 
showed a high variability of their spa type (Table 3). For 14 strains, we determined new 
repeat successions including unidentified 24-bp repeats thus defining new spa types. Among 
them, strains S7926 and S7262, isolated respectively in deep seated soft tissue and sputum 
sample from unrelated infected patients, presented the same spa type t6956 (Table 3). 
Together these data excluded the clonal origin of all edin-C positive S. aureus in our survey.   
 
Antibiotic susceptibility profiles 
 
We next investigated whether edin-positive strains were associated with specific antibiotic 
resistance profiles, such as community-acquired methicillin resistant S. aureus ST80 and 
fusidic acid-resistant impetigo clones [20, 21]. In relation with these studies, we determined 
the minimum inhibitory concentrations (MICs) of edin-positive strains for the following 
antibiotics: penicillin G, methicillin, erythromycin, clindamycin and fusidic acid. Fourteen 
edin-positive strains were susceptible to all tested antimicrobial molecules (41.6 %), except 
fusidic acid. Indeed, one of 14 isolates tested presented only an increase in fusidic acid MIC, 
classified as intermediary sensibility. Twenty two isolates were resistant to penicillin G. 
Among them, 19 were susceptible to all other antimicrobial molecules tested (83%) and two 
strains also presented erythromycin resistance (8.7%). Only one strain, positive for edin-C, 
showed a methicillin-resistance associated to additional resistance, i.e. erythromycin and 
clindamycin as well as an increase of MIC to fusidic acid. This strain was negative for etA 
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and etB. Finally, edin-positive strains did not show any specific resistance profile to classical 
antibiotics used to cure infections by S. aureus (Table 2). 
 
Clinical origin of edin-positive S. aureus 
 
Having shown no link between a high prevalence of edin-C within our S. aureus strains and 
any phenotypic profile or clonal origin, we further analyzed the distribution of edin-positive 
strains with regard to the infectious sites. We noticed that strains positive for edin-C were 
recovered at all sites of infection (Table 4). Strikingly, edin-positive S. aureus were more 
significantly associated with deep-seated infections of soft tissues than other types of 
infections (25.7%, Fischer exact test, p=0.03). No significant association was detected 
between edin-positive or edin-negative strains and other types of infections (blood, urine, 
superficial soft tissue and sputum culture). 
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Discussion 
 
Our study shows that edin-positive S. aureus strains are found in all types of clinical 
infections included in this study, with a global prevalence of 14%. Moreover, we show that 
90% of edin-positive strains are positive for edin-C. This is consistent with a previous study 
performed with specific primers, which also reported a higher prevalence of edin-C in clinical 
strains of S. aureus in Japan [24]. Both studies point for a possible underestimation of the 
prevalence of edin-C in pathogenic S. aureus. This points for the need of using specific 
primers to detect each edin isoform, especially edin-C, given its high prevalence. 
Both the analysis of spa type and the distribution of various virulence factors among 
edin-positive S. aureus show their high genetic variability. Our results on the distribution of 
MSCRAMMs are consistent with previous findings [25]. Classically, edin and exfoliative 
toxin encoding genes are associated in specific lineages responsible for skin infections [17, 
21, 24]. Interestingly, here we show that edin-C is not strictly associated with genes encoding 
exfoliative toxin of serotypes A/B/D (7 strains edin-C-positive and et-positive, versus 25 
strains edin-C-positive and et-negative). The high prevalence of edin-C-positive and et-
negative strains observed in our study might be explained by the plasticity of the pETB 
plasmid, which has been previously reported in two different variants [18, 21]. Also, a recent 
study shows genetic variations in pathogenicity islands encoding EDIN-B [17]. 
Given that spa analysis constitutes a good tool for epidemiological typing of S. aureus 
[26], the use of this method allowed us to exclude the clonal origin of edin-C positive strains.  
The fact that edin-C is plasmid born might explain its presence in strains of various genetic 
backgrounds. 
S. aureus positive for edin are more frequently associated with deep-seated infections of 
soft tissues. Infection of endothelial cells, and other cell types, by EDIN-producing S. aureus 
triggers the formation of transcellular tunnels named macroapertures [12, 13]. Moreover, we 
recently reported that S. aureus EDIN toxin promotes formation of infection foci in a mouse 
model of bacteremia [15]. Together with the present study, this suggests that EDIN might 
enhance the invasive capacity of S. aureus. However, whether or not edin-positive S. aureus 
is preferentially associated with a specific type of deep seated infection remains to be further 
determined. 
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Figure legend 
 
Fig. 1 Characterization of the three edin alleles. A) PCR amplification of edin-A, edin-B and 
edin-C from S. aureus strains S25edin-A(+)[15], S7256edin-B(+) and S7475edin-C(+) (this 
study), respectively, using specific oligonucleotides edinA, edinB, edinC (Table 1) and the 
previously described edin oligonucleotides referred as edinX  [19]. B) Sequence alignments of 
edin-A, edin-B and edin-C showing sequence homologies and localization of each 
oligonucleotide (underlined: edinX; highlighted: edinA, edinB and edinC). 
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Table 1: Oligonucleotides primers used in this study 
 
Gene  Primer sequences Size 
(kb) 
References 
edinA Sense 5’-GGAGATATTAATAAGCTAGATTC-3’ 
Antisense 5’-ATTTTCTTTTTATCATTTGACAATTCT-3’ 
455 This study 
edinB Sense 5’-GGTGACGTGAACAAATTATCCGA-3’ 
Antisense 5’-ATCTTTCTTTTGTTATCAGAAAGTTTA-3’ 
455 This study 
edinC Sense 5’-CGCCATTAAGGTCTAGTCAAGG-3’ 
Antisense 5’-TAGGTCTTCCAGCTAATGCAGC-3’ 
320 This study 
bbp Sense 5’-AACTACATCTAGTACTCAACAACAG-3’ 
Antisense 5’-ATGTGCTTGAATAACACCATCATCT-3’ 
575 [25] 
cna Sense 5’-GTCAAGCAGTTATTAACACCAGAC-3’ 
Antisense 5’-AATCAGTAATTGCACTTTGTCCACTG-3’ 
423 [25] 
ebpS Sense 5’-CATCCAGAACCAATCGAAGAC-3’ 
Antisense 5’-CTTAACAGTTACATCATCATGTTTATCTTTG-3’ 
186 [25] 
fnbA Sense 5’-GTGAAGTTTTAGAAGGTGGAAAGATTAG -3’ 
Antisense 5’-GCTCTTGTAAGACCATTTTTCTTCAC-3’ 
643 [25] 
fnbB Sense 5’-GTAACAGCTAATGGTCGAATTGATACT-3’ 
Antisense 5’-CAAGTTCGATAGGAGTACTATGTTC-3’ 
524 [25] 
fib Sense 5’-CTACAACTACAATTGCCGTCAACAG-3’ 
Antisense 5’-GCTCTTGTAAGACCATTTTCTTCAC-3’ 
404 [25] 
clfA Sense 5’-ATTGGCGTGGCTTCAGTGCT-3’ 
Antisense 5’-CGTTTCTTCCGTAGTTGCATTTG-3’ 
292 [25] 
clfB Sense 5’-ACATCAGTAATAGTAGGGGGCAAC-3’ 
Antisense 5’-TTCGCACTGTTTGTGTTTGCAC-3’ 
205 [25] 
eno Sense 5’- ACGTGCAGCAGCTGACT-3’ 
Antisense 5’- CAACAGCATYCTTCAGTACCTTC-3’ 
302 [25] 
sea  Sense 5’-GCAGGGAACAGCTTTAGGC-3’ 
Antisense 5’-GTTCTGTAGAAGTATGAAACACG-3’ 
520 [27] 
seb Sense 5’-ATGTAATTTTGATATTCGCAGTG-3’ 
Antisense 5’-TGCAGGCATCATATCATACCA-3’ 
683 [27] 
sec Sense 5’-CTTGTATGTATGGAGGAATAACAA-3’ 283 [27] 
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Antisense 5’-TGCAGGCATCATATCATACCA-3’ 
sed Sense 5’-GTGGTGAAATAGATAGGACTGC-3’ 
Antisense 5’-ATATGAAGGTGCTCTGTGG-3’ 
384 [27] 
see Sense 5’-TACCAATTAACTTGTGGATAGAC-3’ 
Antisense 5’-CTCTTTGCACCTTACCGC-3’ 
170 [27] 
seg Sense 5’-CGTCTCCACCTGTTGAAGG-3’ 
Antisense 5’-CCAAGTGATTGTCTATTGTCG-3’ 
327 [27] 
seh Sense 5’-CAACTGCTGATTTAGCTCAG-3’ 
Antisense 5’-GTCGAATGAGTAATCTCTAGG-3’ 
360 [27] 
sei Sense 5’-CAACTCGAATTTTCAACAGGTAC-3’ 
Antisense 5’- CAGGCAGTCCATCTCCTG-3’ 
465 [27] 
sej Sense 5’- CATCAGAACTGTTGTTCCGCTAG-3’ 
Antisense 5’- CTGAATTTTACCATCAAAGGTAC-3’ 
142 [27] 
sek Sense 5’- ATGGCGGAGTCACAGCTACT-3’ 
Antisense 5’-TGCCGTTATGTCCATAAATGTT-3’ 
197 [27] 
seq Sense 5’-GAACCTGAAAAGCTTCAAGGA-3’ 
Antisense 5’-ATTCGCCAACGTAATTCCAC-3’ 
209 [27] 
eta  Sense 5’-CTAGTGCATTTGTTATTCAA-3’ 
Antisense 5’-TGCATTGACACCATAGTACT-3’ 
119 [28] 
etb Sense 5’-ACGGCTATATACATTCAATT-3’  
Antisense 5’-TCCATCGATAATATACCTAA-3’ 
200 [28] 
etd Sense 5'-ATGACTAAAAATATATTAAAAAGTT-3’ 
Antisense 5‘-CTAATGAGACTGTAATTCAGC-3’ 
846 This study 
lukPV Sense 5’-ATCATTAGGTAAAATGTCTGGACATGATCCA-3’ 
Antisense 5’-GCATCAASTGTATTGGATAGCAAAAGC-3’ 
433 [29] 
lukE Sense 5’-TGAAAAAGGTTCAAAGTTGATACGAG-3’ 
Antisense 5’-TGTATTCGATAGCAAAAGCAGTGCA-3’  
269 [29] 
tst-1 Sense 5’-GCTTGCGACAACTGCTACAG-3’ 
Antisense 5’-TGGATCCGTCATTCATTGTTAA-3’ 
559 [27] 
agr1 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-GTCACAAGTACTATAAGCTGCGAT-3’ 
439 [30] 
agr2 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-TATTACTAATTGAAAAGTGC CATAGC-3’ 
572 [30] 
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agr3 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-GTAATGTAATAGCTTGTATAATAATACCCAG-3’ 
321 [30] 
agr4 Sense 5’-ATGCACATGG TGCACATGC-3’ 
Antisense 5’-CGATAATGCCGTAATACCCG-3’ 
657 [30] 
spa Sense5’-TGTAAAACGACGGCCAGTTAAAGACGATCCTTCGGTGAGC-3’ 
Antisense5’-CAGGAAACAGCTATGACCCAGCAGTAGTGCCGTTTGCTT-3’ 
 [23] 
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Table 2: Virulence profile and antibiotic susceptibility of clinical edin-positive S. aureus strains. 
n % n % n % n % n % n %
Virulence profile
MSCRAMMs
bbp 0 0 3 27 3 75 3 30 6 67 15 42
cna 1 50 9 82 4 100 10 100 8 89 32 89
ebpS 0 0 5 45 1 25 6 60 6 67 18 50
fnbA 1 50 7 64 1 25 5 50 5 56 19 53
fnbB 1 50 11 100 4 100 7 70 8 89 31 86
fib 2 100 10 91 4 100 7 70 9 100 32 89
clfA 2 100 11 100 4 100 10 100 9 100 36 100
clfB 2 100 11 100 4 100 10 100 9 100 36 100
eno 2 100 11 100 4 100 10 100 9 100 36 100
SEs
sea 1 50 10 91 3 75 9 90 9 100 32 89
seb 1 50 7 64 2 50 8 80 6 67 24 67
sec 1 50 7 64 2 50 10 100 6 67 26 72
sed 0 0 8 73 3 75 6 60 6 67 23 64
see 0 0 0 0 0 0 0 0 0 0 0 0
sek 1 50 5 45 1 25 7 70 2 22 16 44
seq 1 50 3 27 1 25 5 50 5 56 15 42
seg 2 100 10 91 2 50 10 100 9 100 33 92
seh 0 0 0 0 0 0 0 0 1 11 1 3
sei 2 100 11 100 2 50 9 90 8 89 32 89
sej 0 0 1 9 0 0 2 20 1 11 4 11
tst-1 2 100 6 55 1 25 7 70 5 56 21 58
etA 0 0 2 18 0 0 2 20 2 22 6 17
etB 1
&
50 4
$
36 0 0 2 20 1 11 8 22
etD 0 0 0 0 1* 25 1* 10 0 0 2 6
lukPV 0 0 1 9 1 25 0 0 3 33 5 14
lukE 2 100 8 73 3 75 5 50 4 44 24 67
agr group
agr1 1 50 3 27 3 75 6 60 5 56 18 50
agr2 1 50 3 27 1 25 1 10 0 0 6 17
agr3 0 0 3 27 0 0 0 0 3 33 6 17
agr4 0 0 2 18 0 0 3 30 1 11 6 17
antibiotic resistance profile
penicillin G 1 50 5 45 2 50 8 80 6 67 22 61
Methicillin 0 0 0 0 0 0 0 0 1 11 1 3
Erythromycin 0 0 1 9 0 0 1 10 1 11 3 8
Clindamycin 0 0 0 0 0 0 0 0 1 11 1 3
Fusidic acid 0 0 0 0 1¤ 25 0 0 1¤ 11 2 6
* Edin B positive strains
$
 Edin A  positive for one strain
& 
EdinA positive strain
¤ Increase in fusidic acid MIC, classified as intermediary sensibility
blood (n=2)
superficial soft tissue 
(n=11)
urine sample (n=4) sputum sample (n=10)
deep-seated soft tissue 
(n=9)
total (n=36)
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Table  3 : spa-type of 36 edin-positive Staphylococcus aureus isolates. 
 
Strains EDIN type Spa-type or repeat sequences MLST 
Blood 
S25 A t6403 - 
S7232 C NT
$
 - 
Deep-seated soft tissue  
S7272 C t6953 - 
S7404 C t6649 - 
S7408 C t6484 - 
S7466 C t012 ST-30 
S7595 C NT - 
S7600 C t6677 - 
S7926 C t6956 - 
S8028* C NT - 
S8087 C t6481 - 
Sputum sample 
S7225 C t2726 - 
S7259 C t2088 - 
S7262 C t6956 - 
S7413 C t6483 - 
S7535 C t2647 - 
S7634 C t6954 - 
S7649 B NT - 
S7920 C NT - 
S7965 C NT - 
S8100 C t015 ST-45 
Superficial soft tissue 
S7181 C t6650 - 
S7183 C NT - 
S7436 C t6957 - 
S7475 C t6480 - 
S7526 C t137 - 
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S7539 C NT - 
S7569 A t031 ST-45 
S7599 C t6482 - 
S7932 C NT - 
S7938 C t620 - 
S7977 C NT - 
Urine sample 
S7256 B t078 ST-26 
S7322 C t012 ST-30 
S7906 C t645 - 
S7946 C t216 ST-59 
* MRSA strain 
$
 Not typable 
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Table 4: Presence of edin genes in 256 Staphylococcus aureus strains associated with various 
clinical syndromes. 
Source of isolates (N) 
Number of edin 
isolates       (%) 
edin-isoforms 
edinA edinB edinC 
Blood (28) 2 (7.1) 1 0 1 
Urine (41) 4 (9.8) 0 1 3 
Superficial soft tissue (83) 11 (13.3) 1 0 10 
Deep-seated soft tissue (35) 9 (25.7)* 0 0 9 
Sputum (69) 10 (14.5) 0 1 9 
Total (256) 36 (14) 2 (5) 2 (5) 32 (90) 
* p<0,05 (Fisher’s exact test) 
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